Lyell Immunopharma, Inc. (LYEL)

23.76 +0.83 (+3.62%) USD  |  NASDAQ  |  Jan 16, 16:00
23.86 +0.10 (+0.42%) After-Hours: 20:00
More

Lyell Immunopharma Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade